Toggle navigation
Home
Search
Services
Blog
Contact
About
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F.
Baker Norton Pharmaceuticals, Inc., Miami, FL, United States
Search 7 grants from Elliot Hahn
Search grants from Baker Norton Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Developmental studies to inform clinical stratification and targeting of SHH MB
Prevention of Weight Gain in Young Adults
Pathogenesis of viral meningitis
Reperfusion Effects on Cerebral Artery Function
Hyperglycemia Effect on Forebrain & Brainstem Activation From Rectal Distention
Recently added grants:
Glucagon Regulation by A Novel Brown Adipose Factor
Genetic Control and Ileo-Colonic Mucosal Expression of Bile Acid-Related Mechanisms in Irritable Bowel Syndrome-Diarrhea
Molecular pathways underlying organ-specific targeting by the vagus nerve
High-Resolution, Anisotropic MR Elastography of the Brain
Molecularly targeted photothermal ablation to enhance the therapeutic efficacy of immunomodulatory therapies in hepatocellular carcinoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI028124-03
Application #
2064264
Study Section
Physiological Sciences Study Section (PSF)
Project Start
1989-06-01
Project End
1992-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Baker Norton Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33178
Related projects
NIH 1991
R44 AI
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F. / Baker Norton Pharmaceuticals, Inc.
NIH 1990
R44 AI
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F. / Baker Norton Pharmaceuticals, Inc.
Comments
Be the first to comment on Elliot Hahn's grant